Home › Hopkins and Bayer to develop treatments for eye diseases
 

Keywords :   


Hopkins and Bayer to develop treatments for eye diseases

2015-06-16 14:58:01| Chemicals - Topix.net

The Johns Hopkins University has entered into a five-year agreement with Bayer HealthCare to develop drugs to treat diseases of the eye. Under the agreement, researchers at the Wilmer Eye Institute at Johns Hopkins and Bayer will work together to study things such as biomarkers for back-of-the-eye diseases with few available treatments.

Tags: develop eye diseases treatments

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
09.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
08.11Statement from the U.S. Green Building Council on the 2024 Election Results
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
Chemicals »
15.11
15.11 BLOOD &DEATH HISTORY
15.113
15.11 squier Jazzmaster
15.11 SS6
15.11
15.11pen20087
15.11/
More »